13-CIS-RETINOIC ACID PLUS INTERFERON-ALPHA - A PHASE-II CLINICAL-STUDY IN SQUAMOUS-CELL CARCINOMA OF THE LUNG AND THE HEAD AND NECK

被引：0
|
作者：
ROTH, AD [1 ]
ABELE, R [1 ]
ALBERTO, P [1 ]
机构：
[1] GENEVA UNIV HOSP,DIV ONCOHEMATOL,CH-1211 GENEVA 14,SWITZERLAND
来源：
ONCOLOGY | 1994年 / 51卷 / 01期
关键词：
RETINOID; 13-CIS-RETINOIC ACID; INTERFERON-ALPHA; SQUAMOUS CELL CARCINOMA; RETINOID TOXICITY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Retinoids and interferon-alpha (IFN-alpha) have been shown to have a synergetic antiproliferative and differentiative effect on many cell lines, and in combination they have already been tested with some success in the treatment of some tumors. We investigated the tolerance and efficacy of high dose 13-cis-retinoic acid (2 mg/kg/day) and IFN-alpha in the treatment of advanced squamous cell carcinoma of the lung and of the head and neck. No partial or complete response was observed in the 10 patients treated. The toxicity was unusual and mild to moderate considering the dose of retinoid given. This observation leads us to suspect that IFN-alpha may alleviate some of the side effects of the retinoid, and is of interest in the design of future clinical trials.
引用
收藏
页码：84 / 86
页数：3
相关论文
共 50 条
  • [41] Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck - An Illinois Cancer Center Study
    Rosen, F
    Vokes, EE
    Lad, T
    Kies, M
    Wade, J
    Kilton, LJ
    Blough, R
    French, S
    Mullane, M
    Benson, AB
    INVESTIGATIONAL NEW DRUGS, 1995, 13 (03) : 249 - 252
  • [42] A phase I-II study of 9-cis retinoic acid and interferon-α2b in patients with advanced renal-cell carcinoma:: An NCIC Clinical Trials Group study
    Miller, WH
    Reyno, LM
    Loewen, GR
    Huan, S
    Winquist, E
    Moore, M
    Cato, A
    Jaunakais, D
    Truglia, JA
    Matthews, S
    Dancey, J
    Eisenhauer, E
    ANNALS OF ONCOLOGY, 2000, 11 (11) : 1387 - 1389
  • [43] A phase II trial of interferon-alpha and 5-fluorouracil in patients with advanced renal cell carcinoma - A Southwest Oncology Group Study
    Elias, L
    Blumenstein, BA
    Kish, J
    Flanigan, RC
    Wade, JL
    Lowe, BA
    Goodwin, JW
    Crawford, ED
    CANCER, 1996, 78 (05) : 1085 - 1088
  • [44] Evaluation of Gemcitabine in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Southwest Oncology Group Phase II Study
    Wolfram E. Samlowski
    Holly Gundacker
    J. Philip Kuebler
    Jeffrey K. Giguere
    Glenn M. Mills
    David E. Schuller
    John F. Ensley
    Investigational New Drugs, 2001, 19 : 311 - 315
  • [45] A phase II trial of isotretinoin and alpha interferon in patients with recurrent squamous cell carcinoma of the cervix - A Gynecologic Oncology Group Study
    Look, KY
    Blessing, JA
    Nelson, BE
    Johnson, GA
    Fowler, WC
    Reid, GC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (06): : 591 - 594
  • [46] PHASE I/II STUDY OF ERLOTINIB COMBINED WITH CISPLATIN AND RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Herchenhorn, Daniel
    Dias, Fernando L.
    Viegas, Celia M. P.
    Federico, Miriam H.
    Araujo, Carlos Manoel M.
    Small, Isabelle
    Bezerra, Marcos
    Fontao, Karina
    Knust, Renata E.
    Ferreira, Carlos G.
    Martins, Renato G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : 696 - 702
  • [47] Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A Southwest Oncology Group Phase II study
    Samlowski, WE
    Gundacker, H
    Kuebler, JP
    Giguere, JK
    Mills, GM
    Schuller, DE
    Ensley, JF
    INVESTIGATIONAL NEW DRUGS, 2001, 19 (04) : 311 - 315
  • [48] Stratification by risk factors predicts survival on the active treatment arm in a randomized phase II study of interferon-gamma plus/minus interferon-alpha in advanced renal cell carcinoma (E6890)
    Dutcher, JP
    Fine, JP
    Krigel, RL
    Murphy, BA
    Schaefer, PL
    Ernstoff, MS
    Loehrer, PJ
    MEDICAL ONCOLOGY, 2003, 20 (03) : 271 - 281
  • [49] Interferon-α-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma -: Results of a randomized Phase II study (European Organization for Research and Treatment of Cancer Study 30951)
    Fosså, SD
    Mickisch, GHJ
    De Mulder, PHM
    Horenblas, S
    van Oosterom, AT
    van Poppel, H
    Fey, M
    Croles, JJ
    de Prijck, L
    Van Glabbeke, M
    CANCER, 2004, 101 (03) : 533 - 540
  • [50] Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck - A long term analysis for the Illinois Cancer Center
    Athanasiadis, I
    Taylor, S
    Vokes, EE
    Pelzer, HJ
    Rademaker, A
    Mittal, BB
    Ganzenko, N
    Blough, R
    Lester, EP
    Kies, MS
    CANCER, 1997, 79 (03) : 588 - 594
12345